Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A low grade carcinoma of the kidney characterized by the presence of tubules which are separated by mucinous stroma. Often the tubular structures have a spindle cell appearance. Patients are usually asymptomatic and occasionally they may present with hematuria or flank pain.
Biomarker and diagnostic research for mucinous tubular and spindle renal cell carcinoma has been reported in the published literature.
No clinical trials have been registered for mucinous tubular and spindle renal cell carcinoma.
114 publications have been identified in PubMed for mucinous tubular and spindle renal cell carcinoma. Research spans Basic Science / Preclinical (36%), Case Report / Case Series (31%), and Review / Meta-Analysis (11%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 41 | 36% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 5:38 PM UTC
Program availability and eligibility requirements are set by each foundation. Contact them directly to learn more about your options.
Claim this page and your organization will be listed here for patients and families to find.
European rare disease database
Genetic and Rare Diseases Info Center
Patient case studies
35 |
31% |
Research summaries | 13 | 11% |
Disease patterns and progression | 9 | 8% |
Testing and diagnosis research | 8 | 7% |
New treatment approaches | 5 | 4% |
Clinical study results | 2 | 2% |
Other research | 1 | 1% |
Zhao JX (2026). [PMID: 41852895](https://pubmed.ncbi.nlm.nih.gov/41852895/). *Oncol Lett*. [Case Report / Case Series]
Öztürk A (2026). [PMID: 41943694](https://pubmed.ncbi.nlm.nih.gov/41943694/). *Arch Esp Urol*. [Epidemiology / Natural History]
Williamson SR (2026). [PMID: 42054499](https://pubmed.ncbi.nlm.nih.gov/42054499/). *Am J Surg Pathol*. [Review / Meta-Analysis]
Liu X (2026). [PMID: 40827068](https://pubmed.ncbi.nlm.nih.gov/40827068/). *International journal of surgical pathology*. [Basic Science / Preclinical]
Veros C (2026). [PMID: 42073591](https://pubmed.ncbi.nlm.nih.gov/42073591/). *Cancers (Basel)*. [Review / Meta-Analysis]
Song J (2026). [PMID: 41960572](https://pubmed.ncbi.nlm.nih.gov/41960572/). *Research (Wash D C)*. [Review / Meta-Analysis]
Sun M (2026). [PMID: 41999263](https://pubmed.ncbi.nlm.nih.gov/41999263/). *FASEB J*. [Basic Science / Preclinical]
Hou J (2026). [PMID: 41690476](https://pubmed.ncbi.nlm.nih.gov/41690476/). *Mod Pathol*. [Basic Science / Preclinical]
Bracarda S (2026). [PMID: 41423067](https://pubmed.ncbi.nlm.nih.gov/41423067/). *Critical reviews in oncology/hematology*. [Review / Meta-Analysis]
Zeng WR (2026). [PMID: 41956744](https://pubmed.ncbi.nlm.nih.gov/41956744/). *Zhonghua Bing Li Xue Za Zhi*. [Case Report / Case Series]